MYX mayne pharma group limited

Why doesn’t Richards talk up $200 m + Revenue get a mention now...

  1. 1,530 Posts.
    lightbulb Created with Sketch. 269
    Why doesn’t Richards talk up $200 m + Revenue
    get a mention now upon approval.
    He did when requiring shareholders approval to
    give go ahead to agreement with Mithra.
    Investors understand $$$$ and potentially profitable
    figures more than non toxic, weight loss, bio degradability etc. They may be beneficial but $$ predictions are preferable. Even stating Company could soon be debt free with this approval would see
    accumulation and a re rating. Back into ASX 200.
    Positive comments.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.15
Change
0.130(2.59%)
Mkt cap ! $418.4M
Open High Low Value Volume
$5.05 $5.17 $5.05 $571.9K 111.9K

Buyers (Bids)

No. Vol. Price($)
1 5000 $5.03
 

Sellers (Offers)

Price($) Vol. No.
$5.17 490 1
View Market Depth
Last trade - 16.10pm 30/07/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.